O	O	O	0	4	STAT	STAT	B-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	4	5	-	-	B-PP	HYPH	O	1	P	O
O	O	O	5	12	related	relate	B-NP	VBN	O	5	NMOD	O
O	O	O	13	26	transcription	transcription	I-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	27	34	factors	factor	I-NP	NNS	I-protein	6	SUB	I-protein
O	O	O	35	38	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	39	53	constitutively	constitutively	I-VP	RB	O	6	VMOD	O
O	O	O	54	63	activated	activate	I-VP	VBN	O	6	VC	O
O	O	O	64	66	in	in	B-PP	IN	O	8	VMOD	O
O	O	O	67	77	peripheral	peripheral	B-NP	JJ	B-cell_type	12	NMOD	B-cell_type
O	O	O	78	83	blood	blood	I-NP	NN	I-cell_type	12	NMOD	I-cell_type
O	O	O	84	89	cells	cell	I-NP	NNS	I-cell_type	9	PMOD	I-cell_type
O	O	O	90	94	from	from	B-PP	IN	O	12	NMOD	O
O	O	O	95	100	acute	acute	B-NP	JJ	O	16	NMOD	O
O	O	O	101	109	leukemia	leukemia	I-NP	NN	O	16	NMOD	O
O	O	O	110	118	patients	patient	I-NP	NNS	O	13	PMOD	O
O	O	O	118	119	.	.	O	.	O	6	P	O

O	O	O	121	122	A	A	B-NP	DT	O	4	NMOD	O
O	O	O	123	129	signal	signal	I-NP	NN	O	4	NMOD	O
O	O	O	130	142	transduction	transduction	I-NP	NN	O	4	NMOD	O
O	O	O	143	150	pathway	pathway	I-NP	NN	O	9	SUB	O
O	O	O	151	160	activated	activate	B-VP	VBN	O	4	NMOD	O
O	O	O	161	163	by	by	B-PP	IN	O	5	VMOD	O
O	O	O	164	168	many	many	B-NP	JJ	O	6	PMOD	O
O	O	O	169	178	cytokines	cytokine	I-NP	NNS	B-protein	7	NMOD	B-protein
O	O	O	179	182	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	O	183	191	recently	recently	I-VP	RB	O	9	VMOD	O
O	O	O	192	196	been	be	I-VP	VBN	O	9	VC	O
O	O	O	197	207	elaborated	elaborate	I-VP	VBN	O	11	VC	O
O	O	O	207	208	.	.	O	.	O	9	P	O

O	O	O	209	212	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	213	216	JAK	JAK	I-NP	NN	B-protein	3	NMOD	B-protein
O	O	O	217	224	kinases	kinase	I-NP	NNS	I-protein	15	NMOD	I-protein
O	O	O	225	228	and	and	O	CC	O	15	NMOD	O
O	O	O	229	232	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	233	239	signal	signal	I-NP	NN	B-protein	15	NMOD	B-protein
O	O	O	240	251	transducers	transducer	I-NP	NNS	I-protein	15	NMOD	I-protein
O	O	O	252	255	and	and	I-NP	CC	I-protein	15	NMOD	I-protein
O	O	O	256	266	activators	activator	I-NP	NNS	I-protein	15	NMOD	I-protein
O	O	O	267	269	of	of	B-PP	IN	I-protein	15	NMOD	I-protein
O	O	O	270	283	transcription	transcription	B-NP	NN	I-protein	15	NMOD	I-protein
O	O	O	284	285	(	(	O	(	I-protein	15	NMOD	I-protein
O	O	O	285	289	STAT	STAT	B-NP	NN	I-protein	15	NMOD	I-protein
O	O	O	289	290	)	)	O	)	I-protein	15	NMOD	I-protein
O	O	O	291	298	factors	factor	B-NP	NNS	I-protein	16	SUB	I-protein
O	O	O	299	303	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	304	308	been	be	I-VP	VBN	O	16	VC	O
O	O	O	309	314	found	find	I-VP	VBN	O	17	VC	O
O	O	O	315	317	to	to	I-VP	TO	O	20	VMOD	O
O	O	O	318	320	be	be	I-VP	VB	O	18	VMOD	O
O	O	O	321	330	essential	essential	B-NP	JJ	O	22	NMOD	O
O	O	O	331	341	components	component	I-NP	NNS	O	20	PRD	O
O	O	O	341	342	.	.	O	.	O	16	P	O

O	O	O	343	345	In	In	B-PP	IN	O	6	VMOD	O
O	O	O	346	350	this	this	B-NP	DT	O	3	NMOD	O
O	O	O	351	357	report	report	I-NP	NN	O	1	PMOD	O
O	O	O	357	358	,	,	O	,	O	6	P	O
O	O	O	359	361	we	we	B-NP	PRP	O	6	SUB	O
O	O	O	362	370	describe	describe	B-VP	VBP	O	0	ROOT	O
O	O	O	371	374	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	375	383	presence	presence	I-NP	NN	O	6	OBJ	O
O	O	O	384	386	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	387	401	constitutively	constitutively	B-NP	RB	O	11	AMOD	O
O	O	O	402	411	activated	activate	I-NP	VBN	O	13	NMOD	O
O	O	O	412	416	STAT	STAT	I-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	417	424	factors	factor	I-NP	NNS	I-protein	9	PMOD	I-protein
O	O	O	425	427	in	in	B-PP	IN	O	8	NMOD	O
O	O	O	428	438	peripheral	peripheral	B-NP	JJ	B-cell_type	17	NMOD	B-cell_type
O	O	O	439	444	blood	blood	I-NP	NN	I-cell_type	17	NMOD	I-cell_type
O	O	O	445	450	cells	cell	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	O	451	455	from	from	B-PP	IN	O	17	NMOD	O
O	O	O	456	464	patients	patient	B-NP	NNS	O	18	PMOD	O
O	O	O	465	469	with	with	B-PP	IN	O	19	NMOD	O
O	O	O	470	475	acute	acute	B-NP	JJ	O	22	NMOD	O
O	O	O	476	484	leukemia	leukemia	I-NP	NN	O	20	PMOD	O
O	O	O	484	485	.	.	O	.	O	6	P	O

O	O	O	486	488	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	489	493	used	use	B-VP	VBD	O	0	ROOT	O
T10	B-Entity	B-Entity	494	509	oligonucleotide	oligonucleotide	B-NP	NN	O	4	NMOD	O
T10	I-Entity	I-Entity	510	516	probes	probe	I-NP	NNS	O	19	NMOD	O
O	O	O	517	521	from	from	B-PP	IN	O	4	NMOD	O
O	O	O	522	525	the	the	B-NP	DT	O	15	NMOD	O
T1	B-Protein	B-Protein	526	530	beta	beta	I-NP	SYM	O	15	NMOD	O
T1	I-Protein	I-Protein	530	531	-	-	I-NP	HYPH	O	15	NMOD	O
T1	I-Protein	I-Protein	531	537	casein	casein	I-NP	NN	O	11	NMOD	O
O	O	O	538	541	and	and	I-NP	CC	O	11	NMOD	O
T2	B-Protein	B-Protein	542	545	IRF	IRF	I-NP	NN	B-protein	15	NMOD	B-protein
T2	I-Protein	I-Protein	545	546	-	-	B-NP	HYPH	O	15	NMOD	O
T2	I-Protein	I-Protein	546	547	1	1	I-NP	CD	B-DNA	15	NMOD	B-DNA
T11	B-Entity	B-Entity	548	552	gene	gene	I-NP	NN	I-DNA	15	NMOD	I-DNA
T11	I-Entity	I-Entity	553	562	promoters	promoter	I-NP	NNS	I-DNA	5	PMOD	I-DNA
O	O	O	563	566	and	and	O	CC	O	19	NMOD	O
O	O	O	567	570	the	the	B-NP	DT	O	19	NMOD	O
T12	B-Entity	B-Entity	571	575	ISRE	ISRE	I-NP	NN	B-DNA	19	NMOD	B-DNA
T12	I-Entity	I-Entity	576	581	probe	probe	I-NP	NN	I-DNA	2	OBJ	I-DNA
O	O	O	582	584	to	to	B-VP	TO	O	21	VMOD	O
O	O	O	585	591	detect	detect	I-VP	VB	O	2	VMOD	O
O	O	O	592	596	STAT	STAT	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	O	597	605	proteins	protein	I-NP	NNS	I-protein	21	OBJ	I-protein
O	O	O	606	608	in	in	B-PP	IN	O	21	VMOD	O
O	O	O	609	616	nuclear	nuclear	B-NP	JJ	O	26	NMOD	O
O	O	O	617	625	extracts	extract	I-NP	NNS	O	24	PMOD	O
O	O	O	626	630	from	from	B-PP	IN	O	26	NMOD	O
O	O	O	631	636	acute	acute	B-NP	JJ	B-cell_type	30	NMOD	B-cell_type
O	O	O	637	645	leukemia	leukemia	I-NP	NN	I-cell_type	30	NMOD	I-cell_type
O	O	O	646	651	cells	cell	I-NP	NNS	I-cell_type	27	PMOD	I-cell_type
O	O	O	652	654	in	in	B-PP	IN	O	21	VMOD	O
O	O	O	655	664	bandshift	bandshift	B-NP	NN	O	33	NMOD	O
O	O	O	665	671	assays	assay	I-NP	NNS	O	31	PMOD	O
O	O	O	671	672	.	.	O	.	O	2	P	O

O	O	O	673	681	Specific	Specific	B-NP	JJ	O	5	NMOD	O
O	O	O	682	685	DNA	DNA	I-NP	NN	O	5	NMOD	O
T13	B-Entity	B-Entity	686	693	protein	protein	I-NP	NN	O	5	NMOD	O
T13	I-Entity	I-Entity	694	701	complex	complex	I-NP	NN	O	5	NMOD	O
O	O	O	702	711	formation	formation	I-NP	NN	O	6	SUB	O
O	O	O	712	715	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	716	724	observed	observe	I-VP	VBN	O	6	VC	O
O	O	O	725	729	with	with	B-PP	IN	O	7	VMOD	O
O	O	O	730	733	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	734	740	probes	probe	I-NP	NNS	O	8	PMOD	O
O	O	O	741	745	from	from	B-PP	IN	O	10	NMOD	O
O	O	O	746	749	the	the	B-NP	DT	O	17	NMOD	O
T3	B-Protein	B-Protein	750	754	beta	beta	I-NP	SYM	O	17	NMOD	O
T3	I-Protein	I-Protein	754	755	-	-	I-NP	HYPH	O	17	P	O
T3	I-Protein	I-Protein	755	761	casein	casein	I-NP	NN	O	17	NMOD	O
O	O	O	762	765	and	and	I-NP	CC	O	17	NMOD	O
T4	B-Protein	B-Protein	766	769	IRF	IRF	I-NP	NN	B-protein	21	NMOD	B-protein
T4	I-Protein	I-Protein	769	770	-	-	B-NP	HYPH	O	21	NMOD	O
T4	I-Protein	I-Protein	770	771	1	1	I-NP	CD	B-DNA	21	NMOD	B-DNA
T14	B-Entity	B-Entity	772	776	gene	gene	I-NP	NN	I-DNA	21	NMOD	I-DNA
T14	I-Entity	I-Entity	777	786	promoters	promoter	I-NP	NNS	I-DNA	11	PMOD	I-DNA
O	O	O	786	787	,	,	O	,	O	8	P	O
O	O	O	788	791	but	but	O	CC	O	8	PMOD	O
O	O	O	792	795	not	not	O	RB	O	23	DEP	O
O	O	O	796	800	with	with	B-PP	IN	O	8	PMOD	O
O	O	O	801	804	the	the	B-NP	DT	O	29	NMOD	O
T15	B-Entity	B-Entity	805	809	ISRE	ISRE	I-NP	NN	O	29	NMOD	O
T15	I-Entity	I-Entity	810	825	oligonucleotide	oligonucleotide	I-NP	NN	O	29	NMOD	O
T15	I-Entity	I-Entity	826	831	probe	probe	I-NP	NN	O	25	PMOD	O
O	O	O	831	832	,	,	O	,	O	6	P	O
O	O	O	833	837	when	when	B-ADVP	WRB	O	6	VMOD	O
O	O	O	838	842	cell	cell	B-NP	NN	O	33	NMOD	O
O	O	O	843	851	extracts	extract	I-NP	NNS	O	48	SUB	O
O	O	O	852	856	from	from	B-PP	IN	O	33	NMOD	O
O	O	O	857	862	acute	acute	B-NP	JJ	O	37	NMOD	O
O	O	O	863	876	lymphoblastic	lymphoblastic	I-NP	JJ	O	37	NMOD	O
O	O	O	877	885	leukemia	leukemia	I-NP	NN	O	44	NMOD	O
O	O	O	886	887	(	(	O	(	O	40	DEP	O
O	O	O	887	890	ALL	ALL	B-NP	NN	O	40	DEP	O
O	O	O	890	891	)	)	O	)	O	37	NMOD	O
O	O	O	892	895	and	and	O	CC	O	44	NMOD	O
O	O	O	896	901	acute	acute	B-NP	JJ	O	44	NMOD	O
O	O	O	902	909	myeloid	myeloid	I-NP	JJ	O	44	NMOD	O
O	O	O	910	918	leukemia	leukemia	I-NP	NN	O	34	PMOD	O
O	O	O	919	920	(	(	O	(	O	47	DEP	O
O	O	O	920	923	AML	AML	B-NP	NN	O	47	DEP	O
O	O	O	923	924	)	)	O	)	O	44	NMOD	O
O	O	O	925	929	were	be	B-VP	VBD	O	31	SBAR	O
O	O	O	930	942	investigated	investigate	I-VP	VBN	O	48	VC	O
O	O	O	942	943	.	.	O	.	O	6	P	O

O	O	O	944	946	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	947	951	used	use	B-VP	VBD	O	0	ROOT	O
T16	B-Entity	B-Entity	952	966	nonradioactive	nonradioactive	B-NP	JJ	O	4	NMOD	O
T16	I-Entity	I-Entity	967	983	oligonucleotides	oligonucleotide	I-NP	NNS	O	2	OBJ	O
O	O	O	984	986	as	as	B-SBAR	IN	O	2	VMOD	O
O	O	O	987	998	competitors	competitor	B-NP	NNS	O	5	PMOD	O
O	O	O	999	1001	to	to	B-VP	TO	O	8	VMOD	O
O	O	O	1002	1006	show	show	I-VP	VB	O	2	VMOD	O
O	O	O	1007	1010	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	1011	1022	specificity	specificity	I-NP	NN	O	8	OBJ	O
O	O	O	1023	1025	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	1026	1029	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	1030	1037	complex	complex	I-NP	NN	O	14	NMOD	O
O	O	O	1038	1047	formation	formation	I-NP	NN	O	11	PMOD	O
O	O	O	1047	1048	.	.	O	.	O	2	P	O

O	O	O	1049	1057	Specific	Specific	B-NP	JJ	O	9	SUB	O
O	O	O	1058	1068	antibodies	antibody	I-NP	NNS	B-protein	1	NMOD	B-protein
O	O	O	1069	1077	directed	direct	B-VP	VBN	O	1	NMOD	O
O	O	O	1078	1085	against	against	B-PP	IN	O	3	VMOD	O
O	O	O	1086	1089	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	1090	1100	individual	individual	I-NP	JJ	O	4	PMOD	O
O	O	O	1101	1105	STAT	STAT	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	1106	1114	proteins	protein	I-NP	NNS	I-protein	6	NMOD	I-protein
O	O	O	1115	1119	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1120	1124	used	use	I-VP	VBN	O	9	VC	O
O	O	O	1125	1127	in	in	B-PP	IN	O	10	VMOD	O
O	O	O	1128	1138	supershift	supershift	B-NP	NN	O	13	NMOD	O
O	O	O	1139	1150	experiments	experiment	I-NP	NNS	O	11	PMOD	O
O	O	O	1150	1151	.	.	O	.	O	9	P	O

T5	B-Protein	B-Protein	1152	1157	STAT5	STAT5	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	1157	1158	-	-	I-NP	HYPH	O	1	P	O
O	O	O	1159	1162	and	and	I-NP	CC	O	7	NMOD	O
T6	B-Protein	B-Protein	1163	1168	STAT1	STAT1	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	1168	1169	-	-	O	HYPH	O	7	NMOD	O
O	O	O	1169	1176	related	relate	B-NP	VBN	O	7	NMOD	O
O	O	O	1177	1184	factors	factor	I-NP	NNS	O	8	SUB	O
O	O	O	1185	1189	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1190	1198	detected	detect	I-VP	VBN	O	8	VC	O
O	O	O	1199	1201	in	in	B-PP	IN	O	9	VMOD	O
O	O	O	1202	1205	ALL	ALL	B-NP	NN	O	23	NMOD	O
O	O	O	1206	1209	and	and	I-NP	CC	O	23	NMOD	O
T7	B-Protein	B-Protein	1210	1215	STAT1	STAT1	I-NP	NN	B-protein	23	NMOD	B-protein
O	O	O	1215	1216	-	-	B-NP	HYPH	O	13	P	O
O	O	O	1216	1217	,	,	O	,	O	23	P	O
T8	B-Protein	B-Protein	1218	1223	STAT3	STAT3	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	O	1223	1224	-	-	B-ADJP	HYPH	O	16	P	O
O	O	O	1224	1225	,	,	O	,	O	23	P	O
O	O	O	1226	1229	and	and	O	CC	O	23	NMOD	O
T9	B-Protein	B-Protein	1230	1235	STAT5	STAT5	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	O	1235	1236	-	-	B-NP	HYPH	O	23	NMOD	O
O	O	O	1236	1243	related	relate	I-NP	VBN	O	23	NMOD	O
O	O	O	1244	1252	proteins	protein	I-NP	NNS	O	24	SUB	O
O	O	O	1253	1257	were	be	B-VP	VBD	O	10	SBAR	O
O	O	O	1258	1265	present	present	B-ADJP	JJ	O	24	PRD	O
O	O	O	1266	1268	in	in	B-PP	IN	O	25	AMOD	O
O	O	O	1269	1276	nuclear	nuclear	B-NP	JJ	O	29	NMOD	O
O	O	O	1277	1281	cell	cell	I-NP	NN	O	29	NMOD	O
O	O	O	1282	1290	extracts	extract	I-NP	NNS	O	26	PMOD	O
O	O	O	1291	1295	from	from	B-PP	IN	O	29	NMOD	O
O	O	O	1296	1299	AML	AML	B-NP	NN	O	30	PMOD	O
O	O	O	1299	1300	.	.	O	.	O	8	P	O

O	O	O	1301	1306	Since	Since	B-SBAR	IN	O	17	VMOD	O
O	O	O	1307	1310	the	the	B-NP	DT	O	3	NMOD	O
O	O	O	1311	1316	cells	cell	I-NP	NNS	O	4	SUB	O
O	O	O	1317	1321	were	be	B-VP	VBD	O	1	SBAR	O
O	O	O	1322	1325	not	not	I-VP	RB	O	4	VMOD	O
O	O	O	1326	1333	treated	treat	I-VP	VBN	O	4	VC	O
O	O	O	1334	1338	with	with	B-PP	IN	O	6	VMOD	O
O	O	O	1339	1348	cytokines	cytokine	B-NP	NNS	B-protein	7	PMOD	B-protein
O	O	O	1349	1355	before	before	B-PP	IN	O	6	VMOD	O
O	O	O	1356	1359	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	1360	1367	nuclear	nuclear	I-NP	JJ	B-protein	12	NMOD	B-protein
O	O	O	1368	1376	proteins	protein	I-NP	NNS	I-protein	13	SUB	I-protein
O	O	O	1377	1381	were	be	B-VP	VBD	O	9	SBAR	O
O	O	O	1382	1391	extracted	extract	I-VP	VBN	O	13	VC	O
O	O	O	1391	1392	,	,	O	,	O	17	P	O
O	O	O	1393	1395	we	we	B-NP	PRP	O	17	SUB	O
O	O	O	1396	1404	conclude	conclude	B-VP	VBP	O	0	ROOT	O
O	O	O	1405	1409	that	that	B-SBAR	IN	O	17	VMOD	O
O	O	O	1410	1415	these	these	B-NP	DT	O	20	NMOD	O
O	O	O	1416	1423	factors	factor	I-NP	NNS	O	21	SUB	O
O	O	O	1424	1427	are	be	B-VP	VBP	O	18	SBAR	O
O	O	O	1428	1442	constitutively	constitutively	I-VP	RB	O	21	VMOD	O
O	O	O	1443	1452	activated	activate	I-VP	VBN	O	21	VC	O
O	O	O	1453	1455	in	in	B-ADVP	FW	O	23	VMOD	O
O	O	O	1456	1460	vivo	vivo	I-ADVP	FW	O	24	AMOD	O
O	O	O	1460	1461	.	.	O	.	O	17	P	O

O	O	O	1462	1464	It	It	B-NP	PRP	O	2	SUB	O
O	O	O	1465	1467	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1468	1474	likely	likely	B-ADJP	JJ	O	2	PRD	O
O	O	O	1475	1479	that	that	B-SBAR	IN	O	3	AMOD	O
O	O	O	1480	1483	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	1484	1496	constitutive	constitutive	I-NP	JJ	O	7	NMOD	O
O	O	O	1497	1507	activation	activation	I-NP	NN	O	11	SUB	O
O	O	O	1508	1510	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	1511	1515	STAT	STAT	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	O	1516	1524	proteins	protein	I-NP	NNS	I-protein	8	PMOD	I-protein
O	O	O	1525	1527	is	be	B-VP	VBZ	O	4	SBAR	O
O	O	O	1528	1529	a	a	B-NP	DT	O	13	NMOD	O
O	O	O	1530	1534	part	part	I-NP	NN	O	11	PRD	O
O	O	O	1535	1537	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	1538	1541	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	1542	1548	events	event	I-NP	NNS	O	14	PMOD	O
O	O	O	1549	1551	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	1552	1566	leukemogenesis	leukemogenesis	B-NP	NN	O	17	PMOD	O
O	O	O	1566	1567	.	.	O	.	O	2	P	O
